Hans van Houte - 11 Feb 2025 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRIX	Employee Stock Option (right to buy)	Award	$0	+75,000		$0.000000	75,000	11 Feb 2025	Common Stock	75,000	$17.12	Direct	F1
transaction	NRIX	Restricted Stock Units	Award	$0	+34,300		$0.000000	34,300	11 Feb 2025	Common Stock	34,300	$0.000000	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests as to 1/36 of the total shares monthly beginning March 11, 2025, until the option is fully vested on February 10, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
F4	RSUs do not expire; they either vest or are canceled prior to the vest date.